OPHID’s TB-TAP program aims to strengthen the quality of TB services in a sustainable, cost-effective, responsive, equitable and user-friendly manner to turn off the tap on new transmission and close the leaky tap across the TB cascade. 

Building on OPHID’s successful work of the OPHID TASQC Program, in 2023 OPHID received additional support for the TASQC TB Treatment Access and Prevention (TASQC – TB -TAP). Although significant progress has been made, gaps in access to quality service across the TB cascade remain, from contact tracing, case identification treatment and care.

Grounded in the national TB strategy and leveraging on the current PEPFAR/USAID investments, the program seeks to strengthen client-centred TB services through community initiatives, and support facility systems that reduce disease transmission and progression. The program will build on the existing TB service delivery platforms and facilitate the scale-up of point of care TB testing using Lipo-arabinomannan (LAM) test, adopt use of mobile phone-based TB screening and tracing, optimisation of country-wide GeneXpert Ultra use, and improved documentation through electronic data reporting.

The TB-TAP program seeks to contribute to:

• Improved access to high-quality, person-centred TB, DR-TB, and TB/HIV service
• TB service delivery platforms strengthened.
• TB disease transmission and progression reduced.
• TB research and innovations accelerated with improved impact on program implementation.